Pliant Therapeutics, Inc. (PLRX)
NASDAQ: PLRX · IEX Real-Time Price · USD
11.90
-0.62 (-4.95%)
At close: Apr 24, 2024, 4:00 PM
12.27
+0.37 (3.11%)
After-hours: Apr 24, 2024, 6:43 PM EDT
Pliant Therapeutics Market Cap
Pliant Therapeutics has a market cap or net worth of $716.85 million as of April 24, 2024. Its market cap has decreased by -56.09% in one year.
Market Cap
716.85M
Enterprise Value
232.49M
1-Year Change
-56.09%
Ranking
Category
Stock Price
$11.90
Market Cap Chart
Since June 3, 2020, Pliant Therapeutics's market cap has decreased from $729.40M to $716.85M, a decrease of -1.72%. That is a compound annual growth rate of -0.45%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 23, 2024 | 754.20M | -0.63% |
Apr 22, 2024 | 759.00M | 0.64% |
Apr 19, 2024 | 754.20M | 2.71% |
Apr 18, 2024 | 734.30M | -5.21% |
Apr 17, 2024 | 774.70M | -3.02% |
Apr 16, 2024 | 798.80M | -2.13% |
Apr 15, 2024 | 816.20M | -4.25% |
Apr 12, 2024 | 852.40M | -2.21% |
Apr 11, 2024 | 871.70M | 2.26% |
Apr 10, 2024 | 852.40M | -5.16% |
Apr 9, 2024 | 898.80M | 1.36% |
Apr 8, 2024 | 886.70M | 0.48% |
Apr 5, 2024 | 882.50M | 0.68% |
Apr 4, 2024 | 876.50M | 0.83% |
Apr 3, 2024 | 869.30M | -1.70% |
Apr 2, 2024 | 884.30M | -0.87% |
Apr 1, 2024 | 892.10M | -0.61% |
Mar 28, 2024 | 897.60M | 2.41% |
Mar 27, 2024 | 876.50M | 2.90% |
Mar 26, 2024 | 851.80M | -1.53% |
Mar 25, 2024 | 865.00M | -1.98% |
Mar 22, 2024 | 882.50M | -3.36% |
Mar 21, 2024 | 913.20M | 1.74% |
Mar 20, 2024 | 897.60M | 1.37% |
Mar 19, 2024 | 885.50M | 0.68% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Sage Therapeutics | 778.38M |
ALX Oncology Holdings | 777.36M |
Relay Therapeutics | 773.96M |
BioLife Solutions | 771.01M |
Cytek Biosciences | 760.09M |
Arcturus Therapeutics Holdings | 751.74M |
CARGO Therapeutics | 747.90M |
Ocular Therapeutix | 743.14M |